SkyView Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$828K Sell
5,942
-1,951
-25% -$273K 0.11% 129
2025
Q4
$969K Sell
7,893
-880
-10% -$107K 0.12% 126
2025
Q3
$974K Sell
8,773
-811
-8% -$92.2K 0.12% 128
2025
Q2
$1.06M Sell
9,584
-1,594
-14% -$170K 0.15% 107
2025
Q1
$1.25M Buy
11,178
+3,332
+42% +$344K 0.19% 82
2024
Q4
$725K Sell
7,846
-636
-7% -$57.3K 0.12% 154
2024
Q3
$711K Buy
8,482
+435
+5% +$33.2K 0.12% 133
2024
Q2
$552K Buy
8,047
+947
+13% +$63.2K 0.1% 183
2024
Q1
$520K Buy
7,100
+487
+7% +$37.4K 0.1% 178
2023
Q4
$536K Buy
6,613
+314
+5% +$24.4K 0.13% 87
2023
Q3
$472K Sell
6,299
-6,660
-51% -$512K 0.19% 148
2023
Q2
$1.05M Sell
12,959
-6,937
-35% -$553K 0.26% 114
2023
Q1
$1.65M Sell
19,896
-93
-0.5% -$7.7K 0.39% 62
2022
Q4
$1.72M Sell
19,989
-2,070
-9% -$164K 0.52% 47
2022
Q3
$1.36M Buy
22,059
+2,773
+14% +$175K 0.4% 71
2022
Q2
$1.19M Sell
19,286
-669
-3% -$41.4K 0.31% 96
2022
Q1
$1.2M Buy
19,955
+4,563
+30% +$292K 0.28% 101
2021
Q4
$1.12M Buy
15,392
+11,017
+252% +$759K 0.25% 98
2021
Q3
$306K Buy
+4,375
New +$307K 0.09% 268

Other funds holding GILD

SkyView Investment Advisors's GILD Position: Q1 2026 in Review

SkyView Investment Advisors reduced its Gilead Sciences (GILD) stake by 25% in Q1 2026, selling an estimated $273K and leaving 5,942 shares worth $828K. The position accounts for 0.11% of the portfolio, ranked #129.

SkyView Investment Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.72M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • SkyView Investment Advisors held 5,942 shares of Gilead Sciences worth $828K as of Q1 2026.
  • SkyView Investment Advisors sold 1,951 Gilead Sciences shares in Q1 2026, an estimated $273K.
  • Gilead Sciences made up 0.11% of SkyView Investment Advisors's portfolio in Q1 2026, its #129 holding.
  • SkyView Investment Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • SkyView Investment Advisors's Gilead Sciences position peaked at $1.72M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.